Cardiomyopathy

Welcome to our featured section on cardiomyopathy

Click here to take the CME-accredited courses. 

This educational hub pulls together the latest clinical data, guidelines, congress updates as well as original video content and expert interviews on the management of cardiomyopathies. Some of the content on this hub will be CME-accredited and credits will be available when viewed on Radcliffe Medical Education – our dedicated CME portal. Instructions on how to do so are provided with individual videos. 

 

Close X
Other videos you might like

Section Advisor

Professor Perry Elliott

Chair, Cardiovascular Medicine, University College London, and Head, Clinical Research, UCL Institute of Cardiovascular Science, London, UK

Supported through an educational grant from Bristol Myers Squibb.

Recent Videos

Video

AHA 22 Late-Breaking Science Highlights With Dr Joseph Hill

Joseph A Hill,

Watch time: 5m 4s

Video

AHA 22: Results of the CRISPR-Cas9 First-in-Human Trial

Julian Gillmore,

Watch time: 8m 12s

Video

View from the Thoraxcenter: What's Hot at AHA 2022?

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 15m 30s

Video

HFSA 22: KCCQ Scores In Pts With HCM Treated With Aficamten

Sara Saberi,

Watch time: 15m 24s

Broadcast

Valsartan Sacubitril: Has our PARADIGM shifted?

Giuseppe Rosano, Richard Henry P Tiongco, Rungroj Krittayaphong, et al

Video

ESC 22 Late-breaker Discussion: The REVIVED Trial

Divaka Perera, Harriette Van Spall,

Watch time: 14:31
Chest Pain in the Cancer Patient

European Cardiology Review 2022;17:e15.

Novel Aspects of Classification, Prognosis and Therapy in Takotsubo Syndrome

European Cardiology Review 2019;14(3):191–6

Chagas Disease and Heart Failure: An Expanding Issue Worldwide

European Cardiology Review 2019;14(2):82–8

Hidden in Heart Failure

European Cardiology Review 2019;14(2):89–96

Relationship Between VEGF-C Levels and All-cause Mortality in Patients with Chronic Heart Failure

European Cardiology Review 2018;13(2):129.

A PRMT5 Selective Inhibitor EPZ015666 Suppressed TAC-induced Left Ventricular Dysfunction

European Cardiology Review 2018;13(2):130.

Does Angiotensin Receptor Neprilysin Inhibitor (ARNI) Improve Functional Capacity Assessed by 6 Minutes Walking Test?

European Cardiology Review 2017;12(2):100.

Highlights Of The 2016 European Society Of Cardiology Guidelines On Heart Failure

European Cardiology Review 2017;12(2):76–7

Impact on Patient Care: The 2016 European Heart Failure Guidelines

European Cardiology Review 2017;12(2):78–9

Cardiac Magnetic Resonance in Takotsubo Syndrome

European Cardiology Review 2017;12(1):58–62

Cardiac Repair and Regeneration: The Value of Cell Therapies

European Cardiology Review 2016;11(1):43–8

Left Ventricular Remodelling: A Problem in Search of Solutions

European Cardiology Review 2016;11(1):29–35

Role of the Thyroid System in the Dynamic Complex Network of Cardioprotection

European Cardiology Review 2016;11(1):36–42

Home Blood Pressure Monitoring

European Cardiology Review 2015;10(2):95–101

Tako-tsubo Cardiomyopathy in Patients with Intracerebral Haemorrhage

European Cardiovascular Disease 2006;2(2):1–5

Cardiac Magnetic Resonance Imaging - Role and Applications

European Cardiology 2012;8(1):17-22

Abortion of Acute Myocardial Infarction - The Best Possible Achievement of Reperfusion Therapy

European Cardiology 2008;4(2):52–4

A Selection of Recent Papers as Recommended by the Advisory Panel

European Cardiovascular Disease 2007;3(1):9

Diagnosis of Acute Myocardial Infarction Using Highly Sensitive Cardiac Troponin Assays

European Cardiology 2011;7(1):18–20

Ischaemic Heart Disease - Alternative Treatment Options

European Cardiovascular Disease 2007;3(1):123–5